Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.

Cancer Research (Impact Factor: 9.28). 03/1981; 41(2):650-4.
Source: PubMed

ABSTRACT Administration of aflatoxin B1 (AFB1) to rats resulted in the urinary excretion of 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1. This is the major product formed by the interaction in vivo of AFB1 with rat liver nucleic acids. The adduct was isolated from urine by the combined use of preparative and analytical high-pressure liquid chromatography and was quantitated by measurement of absorbance at 365 nm. The method allowed reproducible quantitation of adduct in urine samples from rats treated with AFB1 by i.p. injection at levels as low as 0.125 mg/kg. Application of the method to urine samples from rats given injections of AFB1 (1 mg/kg) revealed the presence of a compound chromatographically identical to authentic 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1. Spectral and chemical analysis of microgram quantities of this compound provided strong evidence that this compound is identical to authentic adduct. Measurement of this adduct in the urine of rats given injections of different doses of AFB1 showed that excretion occurs in a dose-dependent manner. Comparison of the dose-response curve for adduct excretion with that previously observed for adduct formation in rat liver DNA in vivo revealed a high degree of qualitative similarity, with the levels of adduct excreted in urine representing 30 to 40% of the levels seen initially in liver DNA.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The identification of aflatoxins as human carcinogens has stimulated extensive research efforts, which continue to the present, to assess potential health hazards resulting from contamination of the human food supply and to minimize exposure. The use of biomarkers that are mechanistically supported by toxicological studies will be important tools for identifying stages in the progression of development of the health effects of environmental agents. miRNAs are small non-coding mRNAs that regulate post-transcriptional gene expression. Also, they are molecular markers of cellular responses to various chemical agents. Growing evidence has demonstrated that environmental chemicals can induce changes in miRNA expression. miRNAs are good biomarkers because they are well defined, chemically uniform, restricted to a manageable number of species, and stable in cells and in the circulation. miRNAs have been used as serological markers of HCC and other tumors. The expression patterns of different miRNAs can distinguish among HCC-hepatitis viruses related, HCC cirrhosis-derivate, and HCC unrelated to either of them. The main objective of this review is to find unreported miRNAs in HCC related to other causes, so that they can be used as specific molecular biomarkers in populations exposed to aflatoxins and as early markers of exposure, damage/presence of HCC. Until today specific miRNAs as markers for aflatoxins-exposure and their reliability are currently lacking. Based on their elucidated mechanisms of action, potential miRNAs that could serve as possible markers of HCC by exposure to aflatoxins are miR-27a, miR-27b, miR-122, miR-148, miR-155, miR-192, miR-214, miR-221, miR-429, and miR-500. Future validation for all of these miRNAs will be needed to assess their prognostic significance and confirm their relationship with the induction of HCC due to aflatoxin exposure.
    Frontiers in Microbiology 03/2014; 5:102. DOI:10.3389/fmicb.2014.00102 · 3.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acrylamide (AA), a rodent carcinogen, is widely used in industry and present in cigarette smoke as well as in foods processed at high temperatures. The metabolic activation of AA to glycidamide (GA) could be critical for AA carcinogenicity since GA causes DNA adduct formation in vivo. N7-(2-carbamoyl-2-hydroxyethyl) guanine (N7-GAG), the most abundant DNA adduct of AA, is subjected to spontaneous and enzymatic depurination and excreted through urine. Urinary N7-GAG analysis can confirm AA genotoxicity and identify active species of AA metabolites in humans, thereby serving as a risk-associated biomarker for molecular epidemiology studies. This study aimed to develop an isotope-dilution solid-phase extraction liquid chromatography tandem mass spectrometry method to comparatively analyze urinary N7-GAG levels in nonsmokers and smokers. Urinary N-acetyl-S-(propionamide)-cysteine (AAMA), a metabolite of AA, was also analyzed as a biomarker for current AA exposure. Urinary N7-GAG was quantified by monitoring m/z 239 → 152 for N7-GAG and m/z 242 → 152 for (13)C3-labeled N7-GAG under positive electron spray ionization and multiple reaction mode. The median urinary N7-GAG level was 0.93 μg/g creatinine in nonsmokers (n = 33) and 1.41 μg/g creatinine in smokers (n = 30). Multiple linear regression analysis of data revealed that N7-GAG levels were only significantly associated with AAMA levels. These results demonstrate that urinary N7-GAG of nonsmokers and smokers is significantly associated with a very low level of dietary AA intake, assessed by analyzing urinary AAMA.
    Chemical Research in Toxicology 11/2014; DOI:10.1021/tx500265p · 4.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of the present study was to explore modification in toxico-pathological responses of rats toward aflatoxins (AFs) in the presence of white ginseng. The dietary supplementation with white ginseng (WG) at levels of of 0.0, 1 and 2 % (W/W) of the composition of daily rations, on the performance and toxicity of female Albino rats received aflatoxins-contaminated diets (1.011 mg/kg ration, of dry matter basis), were successively examined for six weeks, as attempt to prevent or minimize the negative probabilities due to ingesting aflatoxin(s) contaminated food. Thirty native apparently healthy female Albino rats with average weight of 100± 3.4 gm., were put under observation for two weeks, then they were divided into five equal groups of six rats each according to their live body weight for performing feeding trials. An exposure study extended for two different stages was conducted using female Albino rats. The 1 st stage (pre-treatment) was suggested to compare the performance of animal groupings under the normal conditions before receiving any treatment, either level of contamination(s) or dosage(s) of additive, such stage extended for 2 weeks. The 2 nd stage (treatment), the animals received different levels of aflatoxin(s) and the food additive (white ginseng), such stage extended for 4 weeks. Rats treated with AFs-contaminated diet alone showed depression, decrease in feed intake, body weight and loose feces. The activities of serum ALT, AST enzymes, which are reflecting liver function, were obviously affected during exposure to aflatoxins, but such levels came back to normal as the level of the WG in the ration increased. Serum urea and creatinine concentrations had also severed and such severe effects came back to moderate when receiving the proposed additive. Livers exhibited fatty change, necrosis and newly formed bile ducts. Lesions in kidney included tubular necrosis and pink homogeneous tubular casts. Rats fed white ginseng only had no significant differences compared to the negative control group (fed on a sole diet without any additives). A concurrent treatment of AFs with white ginseng indicated a potentiation of the animal performance reflected by decreased severity of clinical signs and inccreased body weight gains. The studied food additive minimized and reduced significantly the deterioratsion of such performance which obviously observed in animal grouping received AFs-contaminated diet. Female rats were responding to contaminated diets and to the food additive as well. Thus, our data strongly suggested that deleterious effects of AFs could be overcome or, at least, significantly were diminished by WG. Moreover, this plant by itself did not show any toxic effects.

Preview (2 Sources)

Available from